Click Here to return to the
blue-collar-blog-button.jpg - 3202  Bytes
Blue Collar Politics Blog.

politics-break.gif - 4535 Bytes
rl-art-logo.jpg - 10859 Bytes

To a Directory of Mr.Lederman's Essays

WNV Vaccine Announced by
Co. Linked to Giuliani

by Robert Lederman
robert.lederman@worldnet.att.net

From: FINANCIAL TIMES LONDON 8/1/2000

Peptide Therapeutics, the UK biotech company, said it had been awarded a $3,000,000 grant to develop a new vaccine to combat the mosquito-borne West Nile virus, which killed seven The vaccine will be developed at OraVax, Peptide's US subsidiary, using the company's proprietary ChimeriVax technology."[see below for their detailed press release]

For the past 10 months I have been writing about a bio-chemical corporation, Oravax, in relation to the so-called WNV (West Nile Virus) epidemic in NYC. The V.P of Oravax, Dr. Thomas Monath has been working behind the scenes with Mayor Giuliani, former OEM chief Jerry Hauer, Dr. Cohen and the CDC since the very beginning of this iissue.

From: Newsday 9/25/99-Deadly Discovery

"Virologist Thomas Monath, one of the country's leading authorities on mosquito-carried viruses, called the discovery ``a bombshell,'' and added: `` This is the biggest arbovirus story of the last 50 years. Wow!'' Monath, who works for OraVax, a biotechnology company in Boston, said he has been working closely with CDC investigators in New York since the encephalitis outbreak began in late August. He is assisting federal scientists in trying to figure out a way to deal with the new development."

As predicted, Oravax has now been given a grant from the N.I.H. (National Institute of Health) to create a WNV vaccine. The theory I and a number of other activists have been suggesting is that the entire WNV panic has been created specifically in order to justify the mass distribution of this very vaccine throughout the entire U.S.

Oravax was granted a license by the U.S. Army bio-warfare lab in Ft. Dietrick in 1996 (Monath was previously a researcher at the same lab) to manufacture a Japanese encephalitis vaccine derived from a genetically-altered virus the Army itself created. WNV is a variation of Japanese encephalitis. Numerous medical and scientific institutions, many run by the Federal government, have been quietly experimenting with WNV in NYC and the surrounding area for decades [see references below]. Most of this research involved bio-warfare applications.

According to the press release and articles below the vaccine is a live, attenuated vaccine (it contains live WN virus) and involves "the construction of a chimeric virus in which the envelope genes of yellow fever vaccine are replaced with the corresponding genes of the target West Nile virus". In other words, the plan appears to be to expose the entire nation orally to a genetically-modified form of WNV.

Since the vaccine is made from a genetically-altered strain there is no way to know exactly what other theoretically beneficial or harmful genes may have been added. Scientists in the field of GE foods (genetically-altered foods) have already found evidence that genes in the pollen of these foods can become incorporated into the DNA of insects that pollinate the GE plants. In other words it is possible to incorporate these genes into your own DNA simply by eating the food, or in this instance, orally taking a vaccine.

[From: biotech_activists@iatp.org "Tappeser"
Organization: Oeko-Institute e.V.
Date: Tue, 23 May 2000 15:37:25 +0100
Subject: new stories from Germany

"The German Television ZDF reported on Sunday May 21 that a German researcher found a gene transfer from genetically engineered rapeseed to bacteria and fungi in the gut of honey bees. Prof. Hans-Hinrich Kaatz from the Institut für Bienenkunde (Institute for bee research) at the University of Jena experimented during the last three years with honey bees on an experimental field with transgenic rapeseed in Saxony, Germany."

Mayor Giuliani and his advisors have been massively spraying NYC with a variety of toxic pesticides since last Fall, despite knowing that experts in the field of mosquito control have determined that such spraying actually increases the number of mosquitoes, makes succeeding generations pesticide resistant and increases the incidence of mosquitoes infected with transmissible viruses like WNV by as much as 15 times.

see: Are Mosquito Spray Pesticides Worsening the Encephalitis Problem? http://www.chem-tox.com/brevard/index.htm

SOURCE: Journal of the American Mosquito Control Assoc, Dec;13(4):315-25, 1997 Howard JJ, Oliver New York State Department of Health, SUNY-College ESF, Syracuse 13210, USA.

Also see my articles on this at

Considering the mild nature of WNV their actions appear to be intended to increase WNV rather than to decrease it. Dr. Cohen implied as much two days ago.

NY Post 8/1/2000-
SPRAY IT AIN'T SO!
ROUND 2 ON S.I.

"Cohen said...Part of the reason for the new skeeter woes is that between 10 and 20 percent of the bugs won't be killed by the pesticide [the ones that are resistant to the chemicals] - and those that live will reproduce, Cohen said....Cohen said the traps were nearly empty in the first two days after the initial Staten Island spraying last month, but now they're filling up again. "This is not unexpected," he insisted."

That Dr. Cohen acknowledges he knows that the spraying would lead to new generations of pesticide resistant mosquitoes supports the idea that the spraying is actually intended to help create a demand for the vaccine, which the NYC officials unquestionably knew was already in development and testing. What the real purpose of the vaccine is one can only guess at this point.

From: NY Times 8/7/98
GERM DEFENSE PLAN IN PERIL
AS ITS FLAWS ARE REVEALED.

If you carefully read the very long article this is excerpted from you will see detailed evidence of how Dr. Monath, former Giuliani OEM chief Jerry Hauer, the president of Rockefeller University (where they have experimented with WNV for decades) and Dr. J. Craig Venter, president of The Institute for Genomic Research (the co-researchers and co-owners of the Human Genome Project) have been pressuring President Clinton to spend billions on a nationwide vaccine program against germ warfare.

EXCERPT: "In April, the president...and his top officials met at the White House on April 10 with seven private scientists in the Truman Room, where Cabinet meetings are held. For an hour, participants say, the scientists discussed the germ topic and pushed for a vaccine stockpile. Clinton's attending officials included the secretary of defense, the attorney general, the secretary of health and human services, the director of Central Intelligence and the president's national security adviser. The scientists present were Dr. Frank Young, a former head of the Food and Drug Administration, who moderated the panel; Dr. Joshua Lederberg, president emeritus of Rockefeller University; Dr. Lucille Shapiro, a biologist at Stanford University; Jerome Hauer, head of emergency management for New York City; and Dr. Barbara Rosenberg, a biological arms-control expert at the Federation of American Scientists, a private group. The scientific panel also had two industry experts, both with financial ties to vaccine work. ..Dr. Thomas Monath was identified in a White House announcement as a vice president of OraVax and a former official of the Centers for Disease Control and the U.S. Army Medical Research Institute of Infectious Diseases, the government's top body for defensive germ-warfare studies...Based in Cambridge, Mass., OraVax was founded in 1990 to tap an emerging multi-billion-dollar market in oral vaccines and antibodies to combat infectious diseases. But the small company kept having problems getting beyond research and bringing products to market. By 1996 and 1997, its survival at stake, OraVax tried to win part of the Pentagon's expanding germ work as a subcontractor to make smallpox and other vaccines. By early this year, that work had failed to materialize and the company's stock price was down 90 percent from $10 a share in the initial public offering...."The way to handle it is to be open, so people understand that I may have a potential bias,"Monath said. "I don't make it a business of taking advantage of situations in which I'm asked to participate to push the OraVax agenda."

From: http://info.med.yale.edu/EIINet/MonathSeminar.html

[Note how the VP of Oravax, manufacturer of the encephalitis vaccine who is advising Giuliani on this crisis, was both a researcher at Ft. Dietrick Bio-Warfare lab and a CDC scientist.]

"Thomas Monath is one of the world's leading arbovirologists. He is currently Vice- President of Research and Medical Affairs at OraVax, Inc. in Cambridge, Massachusetts. In this position he is responsible for the scientific direction of programs on vaccine development...Prior to this he was the Chief of the Virology Division, U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick in Maryland. In this position he was responsible for the development of genetically engineered vaccines against arthropod- borne and hemorrhagic fever viruses. Between 1974 and 1988 he was the Medical Director of the Division of Vector- Borne Infectious Diseases at the Centers for Disease Control in Fort Collins, Colorado."

Peptide Awarded Grant by NIH
to Develop West Nile Vaccine
CAMBRIDGE, England, 8/1/2000 /PRNewswire/

-- Peptide Therapeutics Group plc (LSE: PTE.L) ("Peptide") announces that it has been awarded a Fast-Track Small Business Innovative Research (SBIR) grant by the US National Institutes of Health ("NIH") to develop an important new vaccine to prevent West Nile virus disease ("West Nile")...Fears are growing that another outbreak could occur this year. Infected birds and mosquitoes have been detected over a wide area from New Jersey to Massachusetts. Public health warnings have been issued to residents of the affected States, and intensive mosquito control is underway in many areas. There is no vaccine, cure or specific therapy against West Nile virus disease. The US government is actively pursuing a campaign to combat the disease, including funding the development of vaccines for preventative use.

The West Nile vaccine will be developed using Peptide's proprietary ChimeriVax(TM) technology. It will be a live, attenuated vaccine and involves the construction of a chimeric virus in which the envelope genes of yellow fever vaccine are replaced with the corresponding genes of the target West Nile virus. This approach has already been employed by Peptide to develop vaccines against dengue fever (in pre-clinical development) and Japanese encephalitis (due to commence Phase I trials shortly).

Dr. Thomas Monath, Vice President Research & Medical Affairs of Peptide, said: "The advantages of ChimeriVax(TM) vaccines include their high safety profile, ability to induce protection within a few days after a single dose, and long-lasting immunity without the need for booster doses. A ChimeriVax(TM) West Nile vaccine is therefore ideally suited for use in an impending epidemic, where rapid immunization is required."

Dr. John Brown, Chief Executive of Peptide, said: "We are delighted to have been selected by the US government to receive funding to continue to develop our West Nile vaccine. The West Nile virus is one of the most frightening to have emerged in recent years and there is no vaccine available to protect against the disease. We are confident that ChimeriVax(TM) can provide the technology to develop a vaccine that will provide a rapid and effective solution."

For further information visit our web site at www.peptide.co.uk .08/01/2000 11:22 EDT
http://www.prnewswire.com

See: http://www.biospace.com/ for an entire clearinghouse for bio-tech companies

Newsday 9/29/99
-Area Labs Have Long Studied Virus /
Yale, Rockefeller began tests in '50s page A28

"Epidemiologists suspect that the West Nile virus has for the first time been isolated in humans or animals in the Western Hemisphere, but the virus has for decades made its home in several U.S. research laboratories, including Rockefeller University in Manhattan and Yale University in New Haven, Conn. In fact, investigators there were the first to grow and study the West Nile virus in the United States. The work began in the 1950s when unidentified viral samples from around the world arrived at Rockefeller on a steady basis."

Newsday 5/9/2000
Mosquito From Asia Could Carry West Nile

"THE ASSOCIATED PRESS In Army tests at Fort Detrick in Frederick, Md., japonicus was found to be the "most competent vector"[transmittter] for West Nile virus in a laboratory setting, when compared with other mosquitoes."

From: http://www.bioinfo.com/jev.html
[from Federal Register: March 22, 1996 (Volume 61, Number 57, Page 11812)]
DEPARTMENT OF DEFENSE
Notice of Intent To Grant an Exclusive License of a U.S. Government-Owned Patent
Agency: U.S. Army Medical Research and Materiel Command,
DOD [Department of Defense].
Action: Notice.

Summary: In accordance with 37 CFR 404.7 (a)(I)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license of U.S. Patent Application Serial Number 08/348,882, filed November 28, 1994 and entitled ``Infectious DNA Clones of Japanese Encephalitis Virus and Attenuated Strains Japanese Encephalitis Virus Made from the Clones'', to OraVax, Inc., 230 Albany Street, Cambridge, Massachusetts 02139.
[Requests to the Army for further information should be directed to the public affairs officer, Mr. Chuck Dasey (301) 619-2736]

Newsday, 10/10/99 Bugged by Spraying

"The loudest protests heard during the city's recent campaign of insecticide spraying came from the city's tiny Green Party and the artist-agitator Robert Lederman...Yesterday, the head of the mayor's Office of Emergency Management, which took the lead in the assault on the city's mosquito populace, dismissed such concerns as "irresponsible environmental hysteria and stupidity.""If they took a deep breath [of Malathion?] and looked at what we did and what pains we went through to ensure that we did it right and recognize that human life is at stake, they'd get the perspective," said OEM Director Jerry Hauer."

To a Directory of Mr.Lederman's Essays

Important Note:
Mr. Lederman has explained that his articles posted here are not to be taken as official statements by the No-Spray Coalition of which he is a member or of the "No-Spray" lawsuit in which he is a plaintiff.

politics-break.gif - 4535 Bytes

Blue Collar Pundit Essays

Searching for the Breach in
Alice’s Looking Glass World

blue collar break-sm.gif - 872 Bytes

My America

blue collar break-sm.gif - 872 Bytes

Oh Say, Can You See?

blue collar break-sm.gif - 872 Bytes

FREEDOM!

blue collar break-sm.gif - 872 Bytes

War isn't Hell!

blue collar break-sm.gif - 872 Bytes

God is Starting to Scare Me!

blue collar break-sm.gif - 872 Bytes

It's All Part of the Plan!

blue collar break-sm.gif - 872 Bytes

Turning the World Wide Web Into
a Tower of Politically Sanitized Babel

politics-break.gif - 4535 Bytes

And by clicking here, you'll see an old suggestion (May 2003) of how Democrats could/should have protested the Republican convention and G.W. Bush.

This site is under construction

Contact: Jack Ballinger at: Pundit@BlueCollarPolitics.com

politics-break.gif - 4535 Bytes

Click Here to Join the Discussions
in the
Blue Collar Blog!
politics-blue-button.jpg - 8875 Bytes

politics-break.gif - 4535 Bytes

tenant-net.gif - 15095 Bytes
For a great source of general tenant information,
visit the Tenant Net Home Page |

politics-break.gif - 4535 Bytes

citylmts.gif - 3988 Bytes
Click here to view City Limits Magazine

politics-break.gif - 4535 Bytes
©2005 Baltech Productions. All rights reserved.